Poland: Polpharma can acquire part of Bioton

Poland
Available languages: PL

Polpharma’s acquisition of part of Bioton has been approved by UOKiK.

Polpharma SA is Polish manufacturer of drugs and active pharmaceutical ingredients. Bioton SA produces mainly pharmaceuticals used for injections, including recombined human insulin and other biotechnological drugs.

Polpharma is acquiring the part of its business relating to Biodacyna, a drug used to treat eye infections.

Polish competition law requires UOKiK to be notified of an intended merger where the combined turnover of the merging parties in the preceding financial year exceeds €1 billion worldwide or €50 million in Poland.